Skip to main content
Figure 4 | BMC Neurology

Figure 4

From: Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing

Figure 4

Cost-effectiveness of early intervention with a hypothetical disease-modifying treatment in the nine years prior to standard detection and treatment. Panel A net benefits; B Gain in quality-adjusted life years (QALYs); C incremental costs. Treatment effect is a 12-month halt in cognitive deterioration. Costs calculated over a 10-year horizon. Mean cohort age at entry 75 years. Panel A, net benefits; Panel B, gain in quality-adjusted life years (QALYs); Panel C cost savings. Treatment effect is a 12-month halt in cognitive deterioration. Costs calculated over a 10-year horizon. Mean cohort age at entry 75 years.

Back to article page